Arzeda Secures $38M in Oversubscribed Funding Round to Advance Protein Design Commercialization Efforts
Seattle, WA, September 17, 2024 – Arzeda, the Protein Design Company™, today announced the closing of a $38M oversubscribed funding...
Our Intelligent Protein Design Technology™ combines physics-based protein design and AI to create entirely new designer proteins and enzymes more efficiently and with less risk. Our team of scientists and engineers are committed to unlocking the full potential of enzymes by supercharging what happens in nature.